Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-08-27 | 2020-11-12 | 123081 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-09-11 | 2021-01-07 | 124095 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-09-24 | 2020-11-12 | 125004 |
| TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2021-04-01 | 2024-05-30 | 136751 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144682 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196471 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2024-02-08 | 2024-10-11 | 218977 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2025-04-24 | 2025-11-13 | 255709 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263152 |
| TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263155 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2025-10-10 | 2025-11-13 | 269235 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2019-09-19 | 92157 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-17 | 2019-12-19 | 96717 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |